School of Medicine


Showing 301-320 of 523 Results

  • R. Scott Mitchell

    R. Scott Mitchell

    Professor of Cardiothoracic Surgery at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsResearch Interests: Disease of the aorta, congenital and acquired. Treatment of aortic pathology, including development of stent graft systems. Patterns of disease in patients treated with mediastinal radiation. Valvular heart disease, especially aortopathy associated with congenital bicuspid aortic valve.

  • Edward Mocarski

    Edward Mocarski

    Professor of Microbiology and Immunology, Emeritus

    Current Research and Scholarly InterestsMy research interests focused on the biology and pathogenesis of cytomegalovirus (CMV), an opportunistic pathogen that causes significant disease worldwide, reporting discoveries in areas of CMV gene regulation, DNA replication and packaging, maturation, impact on the host cell, disease pathogenesis, latency and reactivation, host cell death signaling and chemokine system. In the last 20 years of my academic career, we studied viral cell death suppressors and discovered ZBP1-RIPK3 necroptosis.

  • Daria Mochly-Rosen

    Daria Mochly-Rosen

    George D. Smith Professor of Translational Medicine

    Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.

  • Stephen B. Montgomery

    Stephen B. Montgomery

    Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science
    On Partial Leave from 06/17/2024 To 08/15/2024

    Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/

  • Ashby Morrison

    Ashby Morrison

    Associate Professor of Biology

    Current Research and Scholarly InterestsOur research interests are to elucidate the contribution of chromatin to mechanisms that promote genomic integrity.

  • Michael Moseley

    Michael Moseley

    Professor of Radiology (Radiological Sciences Lab)

    Current Research and Scholarly InterestsMR physics into tissue contrast mechanisms such as diffusion, perfusion, and functional imaging describes the research direction. Applications of cerebral stroke (brain attacks) and neurocognitive disorders are also being developed from these methods

  • Kara Motonaga

    Kara Motonaga

    Clinical Professor, Pediatrics - Cardiology

    Current Research and Scholarly InterestsArrhythmias in Pediatric and Adult Congenital Heart Disease

  • Sesh Mudumbai

    Sesh Mudumbai

    Associate Professor of Anesthesiology, Perioperative and Pain Medicine
    On Leave from 05/05/2024 To 06/30/2024

    Current Research and Scholarly InterestsDr. Mudumbai’s research interests focus on 1) optimizing therapeutic strategies and reducing adverse outcomes related to medication management, particularly opioids; and 2) measuring and improving the quality of perioperative and pain management.

  • Claudia Mueller

    Claudia Mueller

    Associate Professor of Surgery (Pediatric Surgery)

    Current Research and Scholarly InterestsInvestigations of how children's beliefs of health affect their responses to illness.

  • Daniel Murphy

    Daniel Murphy

    Professor of Pediatrics (Cardiology), Emeritus

    Current Research and Scholarly InterestsDr. Murphy's major interests are in noninvasive cardiology and clinical pediatric and adult congenital cardiac disease. These clinical interests range from imaging of complex cardiac disease in the fetus and newborn to care of the adult with congenital heart disease. He also coordinates the Marfan clinic at LPCH. He is the director of the Adult Congenital Cardiac Clinic at Stanford University Medical Center.

  • Jonathan N. Myers

    Jonathan N. Myers

    Clinical Professor (Affiliated), Medicine - Med/Cardiovascular Medicine

    BioDr. Myers is a Health Research Scientist at the Palo Alto VA Health Care System; a Clinical Professor at Stanford University (Affiliated), and a Senior Research Career Scientist Award recipient through the VA Rehabilitation Research and Development Program. His research has focused on primary and secondary prevention, and the clinical applications of exercise testing and rehabilitation in patients with cardiovascular disease and other chronic conditions. He has a lengthy history of studying the epidemiology of cardiopulmonary exercise test responses, physical activity patterns, and other lifestyle factors and their relation to health outcomes. He manages the Veterans Exercise Testing Study (VETS), an ongoing, prospective evaluation of Veteran subjects referred for exercise testing for clinical reasons, designed to address exercise test, clinical, and lifestyle factors and their association with health outcomes.

    He earned his bachelor’s degree from the University of California, Santa Barbara, his master's degree from San Diego State University, and his doctorate from the University of Southern California. He has been a board member for many organizations including the American Heart Association (AHA), the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and the American College of Sports Medicine (ACSM), and serves on the editorial board for 9 journals. He is a recipient of the Michael Pollock Established Investigator Award through the AACVPR, a recipient of the Steven N Blair Award for excellence in physical activity research from the AHA Council on Epidemiology and Prevention and is the 2022 recipient of the American College of Sports Medicine Citation Award. He is a fellow of the AACVPR, ACSM, American College of Cardiology, and the AHA, and has authored and co-authored guidelines on exercise testing and rehabilitation for each of these organizations, including the 2021 editions of the ACSM and AACVPR guidelines.

  • Ronjon Nag

    Ronjon Nag

    Summer CSP Instructor

    BioRonjon Nag is an inventor, teacher and entrepreneur. He is an Adjunct Professor in Genetics at the Stanford School of Medicine, becoming a Stanford Distinguished Careers Institute Fellow in 2016. He teaches AI, Genes, Ethics, Longevity Science and Venture Capital. He is a founder and advisor/board member of multiple start-ups and President of the R42 Group, a venture capital firm which invests in, and creates, AI and Longevity companies. As an AI pioneer of smartphones and app stores, his companies have been sold to Apple, BlackBerry, and Motorola. More recently he has worked on the intersection of AI and Biology. He has been awarded the IET Mountbatten Medal by the Institution of Engineering and Technology, the 2021 IEEE-SCV Outstanding Engineer Award, the $1m Verizon Powerful Answers Award, the 2023 COX AI Lifetime Achievement Award, the 2023 MIT Great Dome Award, and is the 2024 Inductee in the Silicon Valley Engineering Hall of Fame. Professor Nag has a Ph.D from Cambridge, an M.S from Massachusetts Institute of Technology and a B.Sc. from Birmingham in the UK. He has numerous interests in the intersection of AI and Healthcare including being CEO of Agemica.ai working on creating a vaccine for aging.

    He has many firsts including:

    Firsts:

    • First laptop with speech recognition built-in (with Apricot, 1984)
    • First selling cursive handwriting recognition (with Lexicus, 1991)
    • First speech recognition phones (with Lexicus/Motorola, 1996)
    • First large-vocabulary Chinese speech recognition (with Lexicus/Motorola, 1996)
    • First Chinese predictive text system on a phone (Lexicus/Motorola, 1997)
    • First predictive text systems in 40 languages on Motorola phones, (Lexicus/Motorola, 1997)
    • First touch screen mobile phone with handwriting recognition (Lexicus/Motorola, 1999)
    • First combined mobile search engine and directory (with Cellmania, 2000)
    • First private label downloadable operator billable apps store (Cellmania, 2000)
    • First BlackBerry Operator Billing apps store (Cellmania,2010)
    • First Neural Network Artificial Intelligence System in the Cloud (Ersatz Labs, 2014)
    • First Throwable 360 Ball Camera (Bounce Imaging, 2015)
    • First Android powered smart light switch (Brightswitch 2017)
    • First blood pressure watch with temperature and pulse oximetry add-ons for Back to Work Covid Kit (GTCardio 2019)
    • First no code AI life sciences app store (Superbio.ai 2022)
    • First proposal for an aging vaccine (Agemica 2023)

  • Hiromitsu (Hiro) Nakauchi

    Hiromitsu (Hiro) Nakauchi

    Professor of Genetics (Stem Cell)

    Current Research and Scholarly InterestsTranslation of discoveries in basic research into practical medical applications

  • Sandy Napel

    Sandy Napel

    Professor of Radiology (Integrative Biomedical Imaging Informatics), Emeritus

    Current Research and Scholarly InterestsMy research seeks to advance the clinical and basic sciences in radiology, while improving our understanding of biology and the manifestations of disease, by pioneering methods in the information sciences that integrate imaging, clinical and molecular data. A current focus is on content-based radiological image retrieval and integration of imaging features with clinical and molecular data for diagnostic, prognostic, and therapy planning decision support.

  • Sanjiv Narayan

    Sanjiv Narayan

    Professor of Medicine (Cardiovascular Medicine)
    On Partial Leave from 09/05/2023 To 06/30/2024

    Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.